Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Ownership
|
Insiders
Bullboard - Stock Discussion Forum
NRX Pharmaceuticals Inc
NRXP
Financial Services
Healthcare
Biotechnology
NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing therapeutics based on its N-methyl-D-aspartate (NMDA) platform for the treatment of central nervous system disorders, specifically suicidal depression, chronic pain, and PTSD. It is developing NRX-100 (preservative-free intravenous ketamine) and NRX-101, (oral D-cycloserine/lurasidone). NRX-100 has been awarded...
Fast Track Designation for the treatment of Suicidal Ideation in Depression, including Bipolar Depression. NRX-101 has been awarded Breakthrough Therapy Designation for the treatment of suicidal bipolar depression. NRx has filed an Abbreviated New Drug Application (ANDA) and initiated a New Drug Application filing for NRX-100 (IV ketamine) with an application for the Commissioner’s National Priority Voucher Program for the treatment of suicidal depression. Its subsidiary, HOPE Therapeutics, Inc., is a healthcare delivery company that is building a network of interventional psychiatry clinics.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:NRXP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(0)
•••
PressRelease
X
Post by
PressRelease
on Jul 29, 2025 8:03am
New Press Release - NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Join Fireside Chat at BTIG Virtual Biotech Conference July 29 - 30, 2025
WILMINGTON, Del., July 29, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", or the "Company"), today announced that its CEO and Chairman will join a fireside chat at BTIG Virtual Biotechnology Conference on July 29 – 30, 2025.Prof. Jonathan Javitt, MD, MPH...
read article.
(246)
•••
Guytorule
X
Comment by
Guytorule
on Jul 04, 2025 1:18pm
RE:RE:RE:New front runner for FDA Ketamine Approval !!!
Latest News release from PharmaTher (PHRM) and OTCNASDAQ (PHRRF)....Enjoy the read... Pharmather receives FDA approval goal date for ketamine 2025-07-02 17:47 ET - News Release Mr. Fabio
...more
(246)
•••
Guytorule
X
Comment by
Guytorule
on Jul 04, 2025 12:30pm
RE:RE:New front runner for FDA Ketamine Approval !!!
Further...PharmaTher (THRM) will be disrupting the entire suppy chain for Ketamine once they get FDA approval very shortly by August 9th 2025 and within 90 days Ketamine gets removed from the FDA"
...more
(246)
•••
Guytorule
X
Comment by
Guytorule
on Jul 04, 2025 6:53am
RE:New front runner for FDA Ketamine Approval !!!
Also listed IN U.S on "OTCNASDAQ" under PHRRF....
(246)
•••
Guytorule
X
Post by
Guytorule
on Jul 04, 2025 6:48am
New front runner for FDA Ketamine Approval !!!
Front runner and soon to become key leader to bring Ketamine to market world wide is PHARMATHER (PHRM) listed on Canadian exchange. They have been working on this Drug Ketamine IV presently on the
...more
(19)
•••
Sailormark
X
Comment by
Sailormark
on Jul 01, 2025 1:07pm
RE:DD for NRXP
Have you looked at PHRM? It's along the same lines as this stock. And it's much cheaper..
(14)
•••
MasterJediJazz2
X
Post by
MasterJediJazz2
on Jan 28, 2025 2:14pm
$NRXP $3.65 +28.07% on Today's news! NRx Pharmaceuticals
$NRXP $3.65 +28.07% on Today's news! NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Advances Relationship with Anson Funds with $8.9 Million Financing, Including Above the Market Equity and Senior
...more
(243)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Jan 28, 2025 1:43pm
This stock is a good buy at these low prices and
It should do well for shareholders this year.
(14)
•••
MasterJediJazz2
X
Post by
MasterJediJazz2
on Dec 30, 2024 12:23pm
$NRXP NEWS! NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Filing!
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Initial Section of U.S. New Drug Application to the FDA for NRX-100 (IV Ketamine) for the Treatment of Suicidal Depression https://finance.yahoo.com/news
...more
(0)
•••
LookingAtPharma
X
Post by
LookingAtPharma
on Dec 04, 2024 2:29pm
DD for NRXP
This is not financial advice. NRXP is a stock I've been looking at in the small cap Pharma sector. Here are there three main bullet points from their November 14th statement on Q3 results: On
...more
(10)
•••
MikeTester
X
Post by
MikeTester
on Aug 02, 2024 10:32am
NRX Pharmaceuticals, Inc. (NASDAQ:NRXP) – Developing I
https://beyondspx.com/2024/07/31/nrx-pharmaceuticals-inc-nasdaqnrxp-developing-innovative-cns-therapies/
(29)
•••
flight100
X
Post by
flight100
on May 26, 2022 1:42pm
NRXP is rebounding now 0.57
eom
(29)
•••
flight100
X
Post by
flight100
on May 26, 2022 1:02pm
Buying NRXP at 0.5 It still has $40mil cash in its treasury
As per NRXP financial news, NRXP had $40 million cash as of March 31. So, current price 0.51 is steal and the stock price should move up very quickly. As of March 31, 2022, cash was
...more
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 11, 2021 8:01am
NRXP ...... NR on watch
Do some research
(4)
•••
AviseAnalytics
X
Post by
AviseAnalytics
on Oct 19, 2021 8:05am
ALL YOU NEED TO KNOW ABOUT NRX PHARMACEUTICALS!
$NRXP There is a lot of buzz around NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing ZYESAMI™ (AVIPTADIL®) for the treatment of respiratory
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Silver North Intersects 13.15 m Averaging 818 g/t Silver and 1.39 g/t Gold at the Haldane Property